Evidence map›Paper›PMID 40606287›Full record

ArticleSleep medicine: X2025

Artificial light exposure at night: A hidden risk factor for type 2 diabetes.

Izere Salomon, Shema Sam, Yahya Ur Rehman, Intwari Munyaneza Hope

Abstract read
In one paragraph

Article in Sleep medicine: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Izere SalomonUniversity of Rwanda College of Medicine and Health Sciences, Department of General Medicine and Surgery, Kigali, Rwanda.
Shema SamUniversity Teaching Hospital of Butare (CHUB), Butare, Rwanda.
Yahya Ur RehmanLiaquat University of Medical and Health Sciences, Jamshoro, Pakistan.
Intwari Munyaneza HopeVoronezh State Medical University N.N. BURDENKO, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examines the effect of nighttime light exposure on the risk of developing type 2 diabetes Mellitus (T2DM), highlighting an often-overlooked environmental factor. While lifestyle choices such as diet and physical activity have long been recognized as critical risk factors for T2DM, emerging evidence suggests that artificial light at night (LAN) may also play a significant role. LAN disrupts circadian rhythms, which regulate sleep cycles and glucose metabolism, leading to metabolic dysfunction. Using data from the UK Biobank, researchers assessed the relationship between personal light exposure patterns and T2DM risk. Findings revealed that for every 10-lux increase in LAN, the risk of developing T2DM rises by 30 %. The study underscores the importance of circadian alignment in metabolic health and suggests that mitigating nighttime light exposure, especially in urban environments, could be a practical strategy for reducing T2DM risk. Raising awareness about the health risks of light pollution and advocating for healthier lighting solutions in public spaces could play a crucial role in T2DM prevention. Further research is needed to confirm these findings and explore interventions that reduce nighttime light exposure and its impact on diabetes risk.

Indexed as

Artificial light exposureCircadian rhythmsGlucose metabolismLight at night (LAN)Light pollutionMetabolic healthType 2 diabetes (T2D)

Identifiers

PMID40606287
PMCPMC12221600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.